Cargando…

Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn’s disease

BACKGROUND: Azathiopurine (AZA) is efficacious for maintenance remission of Crohn’s disease (CD) at the standard dose of 2.0-2.5 mg/kg for Caucasian. It has been reported that the lower dose (1.0-2.0 mg/kg) in some Asian countries was as effective as the standard dose. In the present study we analyz...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Jianghong, Gao, Yan, Yang, Chuanhua, Yang, Xueqing, Li, Xuhang, Xiao, Shudong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849559/ https://www.ncbi.nlm.nih.gov/pubmed/24070341 http://dx.doi.org/10.1186/1479-5876-11-235

Ejemplares similares

Low dose of azathioprine is effective to induce and maintain remission in active Crohn disease: A prospective observational study
por: Qian, Xiaoxian, et al.
Publicado: (2018)

Low-dose azathioprine effectively improves mucosal healing in Chinese patients with small bowel Crohn's disease
por: Yu, Li Fen, et al.
Publicado: (2014)

EP1278: EFFICACY OF TOTAL ENTERAL NUTRITION COMBINED WITH AZATHIOPRINE IN MAINTAINING POSTOPERATIVE REMISSION IN CROHN'S DISEASE: A PARALLEL, RANDOMIZED CONTROLLED STUDY
por: Duan, Ming, et al.
Publicado: (2022)

Histological remission of autoimmune hepatitis after the addition of allopurinol and azathioprine dose reduction
por: Guedes, Ana Luiza Vilar, et al.
Publicado: (2017)

Prolonged Remission of Psoriasis with Azathioprine Pulse Therapy
por: Gupta, Ramji
Publicado: (2015)

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course
por: Harris, Rachel E, et al.
Publicado: (2020)

Discontinuation of Azathioprine could be considered in pediatric patients with Crohn’s disease who have sustained clinical and deep remission
por: Jeong, Tae Jong, et al.
Publicado: (2022)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020)

Lactobacillus GG in inducing and maintaining remission of Crohn's disease
por: Schultz, Michael, et al.
Publicado: (2004)

Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease
por: Sollelis, Elisa, et al.
Publicado: (2019)

Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease
por: Connors, William, et al.
Publicado: (2014)

Redox imbalance in Crohn's disease patients is modulated by Azathioprine
por: Tavassolifar, Mohammad Javad, et al.
Publicado: (2021)

Acute Pancreatitis Induced by Azathioprine and 6-mercaptopurine Proven by Single and Low Dose Challenge Testing in a Child with Crohn Disease
por: Yi, Geum-Chae-Won, et al.
Publicado: (2012)

Recalcitrant plantar warts during azathioprine therapy for Crohn’s disease
por: Timmer, Margriet R., et al.
Publicado: (2013)

Resected Hepatocellular Carcinoma in a Patient with Crohn's Disease on Azathioprine
por: Heron, Valérie, et al.
Publicado: (2016)

Azathioprine Is Useful for Maintaining Long-term Remission Induced by Tacrolimus for the Treatment of Ulcerative Colitis: An Inverse Probability of a Treatment Weighing Analysis
por: Nishida, Yu, et al.
Publicado: (2019)

Ustekinumab Successfully Treats and Maintains Remission of Pyostomatitis Vegetans Associated with Crohn’s Disease
por: Abi Doumeth, Sarah, et al.
Publicado: (2020)

A Case of Crohn's Disease with Improvement after Azathioprine-Induced Pancytopenia
por: Choi, Yong Sung, et al.
Publicado: (2011)

Pure red cell aplasia due to azathioprine therapy for Crohn's disease
por: Kamath, Nagesh, et al.
Publicado: (2016)

Increased Risk of Liver Cirrhosis during Azathioprine Therapy for Crohn's Disease
por: Roselli, Jenny, et al.
Publicado: (2020)

HLA variants associated with azathioprine‐induced pancreatitis in patients with Crohn’s disease
por: Ås, Joel, et al.
Publicado: (2022)

Low-Dose Naltrexone-Induced Remission in Hailey–Hailey Disease Maintained in Remission with Topical Combination of Ketamine and Diphenhydramine
por: Sonthalia, Sidharth, et al.
Publicado: (2019)

Spectroscopic correlation and role of Azathioprine in long-term remission in patients of Hashimoto encephalopathy
por: Singh, Harpreet, et al.
Publicado: (2013)

Efficacy and safety of azathioprine during remission of immune-mediated thrombotic thrombocytopenic purpura
por: Bichard, Christian, et al.
Publicado: (2022)

5-Aminosalicylates to maintain remission in Crohn’s disease: Interpreting conflicting systematic review evidence
por: Gordon, Morris
Publicado: (2017)

Recurrent Hepatocellular Carcinoma in Patient with Crohn's Disease: Incidental or Expected Outcome of Azathioprine?
por: Botros, Youssef, et al.
Publicado: (2015)

Low-Dose Azathioprine in Combination with Allopurinol: The Past, Present and Future of This Useful Duo
por: Turbayne, Alexander Keith, et al.
Publicado: (2022)

Fecal microbiota transplantation to maintain remission in Crohn’s disease: a pilot randomized controlled study
por: Sokol, Harry, et al.
Publicado: (2020)

Effect of NUDT15 polymorphisms on early hematological safety of low‐dose azathioprine in Chinese patients with pemphigus vulgaris: A prospective cohort study
por: Zhou, Xingli, et al.
Publicado: (2021)

Pulmonary Mycobacterium avium Infection in a Patient with Crohn's Disease under Azathioprine Treatment
por: Hirano, Tomonori, et al.
Publicado: (2014)

Patients' Educational Program Could Improve Azathioprine Adherence in Crohn's Disease Maintenance Therapy
por: Wang, Lei, et al.
Publicado: (2020)

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
por: Gordon, Morris, et al.
Publicado: (2020)

Ustekinumab is more effective than azathioprine to prevent endoscopic postoperative recurrence in Crohn's disease
por: Buisson, Anthony, et al.
Publicado: (2021)

Non-cirrhotic portal hypertension related to azathioprine therapy in a patient with Crohn’s disease
por: Seo, Jong Won, et al.
Publicado: (2021)

The Role of Probiotics in Inducing and Maintaining Remission in Crohn’s Disease and Ulcerative Colitis: A Systematic Review of the Literature
por: Vakadaris, Georgios, et al.
Publicado: (2023)

Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trial
por: Kiszka-Kanowitz, Marianne, et al.
Publicado: (2022)

How Does It Look in an Autopsy? Hepatosplenic T-Cell Lymphoma in a Patient with Crohn’s Disease on Azathioprine
por: Rastogi, Pulkit, et al.
Publicado: (2020)

Crohn’s disease in remission or simply smouldering?
por: Gaya, Daniel R.
Publicado: (2015)

Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE
por: Panaccione, R, et al.
Publicado: (2013)

Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass
por: He, Zhi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dc429imegtn5vbaukf08pk02cb